NCT05544214View on ClinicalTrials.gov

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 21, 2022

Primary Completion Date

November 14, 2022

Study Completion Date

November 17, 2022

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

CKD-371

PO

Trial Locations (1)

Unknown

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT05544214 - Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects | Biotech Hunter | Biotech Hunter